Polymorphisms in non-HLA genes: Contribution to coeliac disease

Pediatrika

Volumn 16, Issue 9, 1996, Pages 60-66

  Crusius, J B A ^a   Mulder, C J J ^a   Mearin, M L ^a   Pena, A S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coeliac disease; IL 1; Il 1ra; LT; MHC; Polymorphism; TNF

Indexed keywords

EID: 2542464849     PISSN: 02113465     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alphalbeta heterodimer. J. Exp. Med. 1989; 169:345-350.
2. Bolsover WJ, Hall MA, Vaughan RW, Welsh Kl, Ciciitira PJ. A family study confirms that the HLA-DP associations with celiac disease are the result of an extended HLA-DR3 haplotype. Hum Immunol 1991: 31:100-108.
3. Powis SH, Rosenberg WMC, Hall M, et al. TAP1 and TAP2 polymorphism in coeliac disease. Immunogenetics 1993; 38:345-350.
4. Alper CA, Fleischnick E, Awdeh Z, Katz AJ, Yunis EJ. Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy. J Clin Invest 1987; 79:251-256.
5. Partanen J, Milner C, Campbell RD, Maki M, Lipsanen V, Koskimies S. HLA-linked heat-shock protein 70 (HSP70-2) gene polymorphism and celiac disease. Tissue Antigens 1993; 41:15-19.
6. Zimmer KP, Poremba C, Weber P, Ciciitira PJ, Harms E. Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes. Gut 1995; 36:703-709.
7. Maiuri L, Picarelli A, Boirivant M, et al. Definition of the initial immunologie modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 1996; 110:1368-1378.
8. Ciciitira PJ, Sturgess R. Clinicopathologic mechanisms in celiac disease. Curr Opin Gastroenterol 1992; 8:262-267.
9. Przemioslo RT. Lundin KEA, Sollid LM, Nelufer J, Ciciitira PJ. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 1995; 36:874-879.
10. Sturgess RP, Hooper LB, Spencer J, Hung C-H, Nelufer JM, Ciciitira PJ. Effects of interferon-gamma and tumour necrosis factor-alpha on epithelial HLA class-ll expression on jejunal mucosal biopsy specimens cultured in vitro. Scand J Gastroenterol 1992:27:907-911.
11. Kvale D, Brandtzaeg P, Lovhang D. Upregulation of the expression of secretory component and HLA molecules in a human colonie cell line by tumor necrosis factor-alpha and gamma-interferon, Scand J Immunol 1988:28:351-357.
12. Sturgess RP, MaCartney JC, Makgoba MW, Hung CH, Haskard DO, Ciciitira PJ. Differential upregulation of intercellular adhesion molecule-1 in coeliac disease. Clin Exp Immunol 1990; 82:489-492.
13. Smart CJ, Calabrese A. Oakes DJ, Howle PD, Trejdosiewicz LK. Expression of the LFA-1 beta 2 integrin (CD11alCD18) and ICAM-1 (CD54) in normal and coeliac small bowel mucosa. Scand J Immunol 1991; 34:299-305.
14. Sturgess R, Kontakou M, Nelufer J, Hung T, Ciclitira PJ. Gammaldelta T-cell receptor expression in the jejunal epithelium of patients with dermatitis herpetiformis and coeliac disease. Clin Exp Dermatol 1993; 18:318-321.
15. Spies T, Morion CC, Nedospasov SA, Fiers W, Pious D, Strominger JL. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sei USA 1986; 83:8699-8702.
16. Messer G, Spengler U, Jung MC, et al. Allelic variation in the TNF-beta gene does not explain the low TNF-beta response in patients with primary biliary cirrhosis. Scand J Immunol 1991; 34:735-740.
17. Wilson AG, Di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human Tumour Necrosis Factor alpha (TNFalpha) gene detectable by Ncol restriction of PCR product. Hum Mol Gen 1992; 1:353.
18. Ferencik S, Lindemann M, Horsthemke B, GrosseWilde H. A new restriction fragment length polymorphism of the human TNF-B gene detected by AspHI digest. EurJ Immunogenet 1992; 19:425-430.
19. D'Alfonso S, Momigliano FUchiardi P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39:150-154.
20. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86bp tandem repeat. Hum Genet 1993; 91:403-404.
21. Tarlow JK, Blakemore AIF, Cork MJ, et al. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and chronic inflammatory diseases, Lymphokine and Cytokine Res 1993: 12:A181.
22. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37:13801385.
23. Bloque G, Bouma G, Crusius JBA, et al. Evidence for genetic heterogeneity in IBD .1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol 1996; 8:105-110.
24. Bloque G, Crusius JBA, Koutroubakis I, et al. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102:379-383.
25. Jacob CO. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunol Today 1992; 13:122-125.
26. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA. McDevitt HO. Heritable major histocompatibility complex class ll-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sei USA 1990: 87:1233-1237.
27. Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. EurJ Immunol 1993; 23:224-231.
28. Wilson AG, DE Vries N, Pociot F, Dl Giovine FS, Van Der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993: 177:557-560.
29. Mansfield JC, Holden H, Wilson AG, Holdsworth CD, Duff GW. Coeliac disease associates with a polymorphism in the promoter region of the TNFalpha gene which further defines the coeliac haplotype. Gut 1993: 34(suppl 4):S23 (abstr).
30. Brinkman BM, Giphart MJ, Verhoef A, et al. Tumor necrosis factor alpha-308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome. Hum Immunol 1994; 41:259-266.
31. Pociot F, Mlvig J, Wogensen L, et al. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991; 33:37-49.
32. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-beta gene correlates with a variant amlno acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173:209-219.
33. Crusius JBA, Bing X, Mulder CJJ, Mearin ML, Peha AS. Relevance of haplotypes in the TNF region in celiac disease, Eur Cytok Network 1994:2:168.
34. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNFllymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J Immunol 1991: 147:1053-1059.
35. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16:180-186.
36. McManus R, Moloney M, Borton M, et al. Association of celiac disease with microsatellite polymorphisms close to the tumor necrosis factor genes. Hum Immunol 1996; 45:24-31.
37. Bouma G, Crusius JBA, Oudkerk Pool M, et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles - relevance for inflammatory bowel disease. Scand J Immunol 1996; 43:456-463.
38. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL- 1Ra) gene polymorphism. Clin Exp Immunol 1995; 99:303-310.
39. Mandrup-Poulsen T, Pociot F, M0lvig J, et al. Monokine antagonism is reduced in patients with IDDM. Diabetes 1994; 43:1242-1247.
40. Clay FE, Tarlow JK, Cork MJ, Cox A, Nickiin MJH, Duff G W. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Human Genetics 1996; 97:723-726.